摘要
除专利制度外,欧美推行了系列非专利制度,将改良药品纳入了知识产权保护中.对于渐进发展特性十分突出的中药而言,改良与创新同等重要,中药改良产品与创新产品都值得知识产权保护.中药品种保护制度具有发展为中药知识产权特有保护制度的潜力,在探讨其知识产权保护机制时,应对中药创新品种予以"强"保护以达成"激励"效果,对中药改良品种予以"弱"保护以达成"促进"效果.
In addition to the patent system,non-patent protection mechanisms for medicines has been implemented in Europe and America,improved drugs then become the object of intellectual property protection.For traditional Chinese medicine(TCM),which has a very incremental nature,improvement and innovation are equally important.Both of the improved products and innovative products of TCM deserve intellectual property protection.The protection system for varieties of TCM has the potential to develop into a sui generis system for TCM knowledge.When discussing its protetion mechanism of intellectual property rights,the innovative varieties of TCM should be“strongly”protected to achieve“incentive”effect,and the improved varieties of TCM should be“weakly”protected to achieve“promotion”effect.
基金
国家社会科学基金重大项目“中医药传统知识保护专门制度研究”(项目编号:16ZDA236)
浙江省软科学研究计划项目“中药国际科技合作中的知识产权保护机制研究”(项目编号:2018C35082)阶段性研究成果。
关键词
中药创新品种
中药改良品种
非专利保护机制
中药品种保护制度
the Innovative Varieties of TCM
the Improved Varieties of TCM
Non-patent Protection Mechanism
Protection System for Varieties of TCM
